Grants and Contributions:
Title:
Participation in the Canadian Life Sciences co-innovation mission to Japan – October 2025
Agreement Number:
1034967
Agreement Value:
$4,600.00
Agreement Date:
Sep 11, 2025 - Oct 20, 2025
Description:
Participation in the Canadian Life Sciences co-innovation mission to Japan – October 6 to 10, 2025. Delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to explore the Japanese market and to develop international partnerships and potential project ideas under the Japan Program. In Partnership with the Trade Commissioner Service Canadian Technology Accelerator (TCS CTA), and Deep Tech Canada, the Canadian delegation will also receive support for their international business and market-entry strategies, as well as get introductions to other potential partners and clients during the mission.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 1M1
Reference Number:
172-2025-2026-Q2-1034967
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
751921719
Recipient Type:
For-profit organization
Recipient's Legal Name:
QurCan Therapeutics Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254